Indian Stock Market Outlook

The Indian stock market benchmark indices, Sensex and Nifty 50, are expected to open on a positive note on Tuesday, March 17, 2026, building on gains from the previous session. The rally in global markets, driven by strength in technology and AI-linked stocks, is expected to support the Indian equities.

Global Market Performance

Asian markets traded in the green, while the US stock market advanced overnight, driven by strength in technology and AI-linked stocks. The Dow Jones Industrial Average closed nearly 400 points higher, snapping a three-week losing streak as crude oil retreated below the $95 per barrel mark.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Domestic Market Performance

On Monday, March 16, 2026, domestic equities ended with strong gains, aided by late buying in financial, auto, and FMCG stocks, despite lingering geopolitical concerns. The Sensex surged 938.93 points, or 1.26%, to settle at 75,502.85, while the Nifty 50 rose 257.70 points, or 1.11%, to close at 23,408.80.

Stocks to Watch

Reliance Industries: The company has entered into a binding long-term agreement to supply green ammonia to South Korea's Samsung C&T Corporation, marking one of the largest deals globally in the emerging green fuels space.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Tata Motors: The company has announced a price hike of up to 1.5% for its commercial vehicles, effective April 1, 2026, to partly offset rising commodity prices and input costs.

Other Key Developments

• RVNL has secured a ₹95.27 crore contract to carry out the refurbishment of permanent railway tracks and associated infrastructure in Chhattisgarh.
• Ola Electric has initiated plans to raise ₹2,000 crore by divesting a stake in its battery subsidiary, Ola Cell Technologies (OCT).
• Sun Pharma has received approval from the US Food and Drug Administration to broaden the therapeutic use of its innovative drug Ilumya for treating adults with active psoriatic arthritis.
• RailTel Corporation of India has secured a ₹42.63 crore work order, inclusive of taxes, from the National Informatics Centre Services Incorporated for the New Core Link under the National Knowledge Network (NKN) project.
• Gujarat Mineral Development Corporation has entered into a memorandum of understanding (MoU) with NMDC Ltd to explore potential collaboration opportunities in the rare earth elements (REE) sector.
• Power Mech Projects has won a ₹709.56 crore contract from Adani Infrastructure Management Services Ltd for providing operations and maintenance services at a major thermal power plant in Maharashtra.
• Zydus Lifesciences' US-based subsidiary, Sentynl Therapeutics Inc., is set to enter into an agreement with PRG S&T, a South Korean firm focused on developing treatments for rare genetic disorders, to license its investigational drug Progerinin (SLC-D011) for the treatment of Hutchinson-Gilford Progeria Syndrome.